CoChat

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

The Association between Adherence to Levodopa/Carbidopa/Entacapone Therapy and Healthcare Utilization and Costs among Patients with Parkinsonʼs Disease: A Retrospective Claims-Based Analysis

Abstract

Background Suboptimal adherence to long-term therapies is common and may potentially have adverse consequences on patient outcomes and healthcare costs. Objective To assess the association between adherence to levodopa/carbidopa/entacapone therapy and healthcare utilization and costs in patients with Parkinson's disease. Methods A retrospective historical cohort study, conducted in the US, using a health insurance claims database, with data spanning from 1 January 2000 to 31 December 2005. Subjects included patients with Parkinson's disease who were treated with levodopa (L), carbidopa (C) and entacapone (E) either as separate tablets (LC + E) or as a single-tablet formulation (LCE). The association between satisfactory adherence (defined as 'proportion of days covered' for LCE or LC + E during 1-year follow-up ≥80%) and healthcare utilization and costs was examined using multivariate regression to control for pretreatment adherence to LC and other patient characteristics. Results Compared with unsatisfactory adherence (n = 598), satisfactory adherence (n = 617) was associated with 39% fewer Parkinson's disease-related hospitalizations (95% CI 20, 54; p Conclusions Better adherence to levodopa/carbidopa/entacapone therapy is associated with lower healthcare utilization and costs. Non-adherence to LCE is associated with a greater increase in costs than non-adherence to LC + E. Efforts should be made to ensure adherence to both therapies.

Overview

Integrity signals

Registry

Crossref · 10.2165/11538970-000000000-00000

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 20 references

Research works printed but not linked: 2

  1. Farley, 2006, Am J Manag Care, 12, 110
  2. Connor, 2004, Bull World Health Org, 82, 935

Cited by

See all 28

Metadata

Authors
Delea, T. E., Thomas, S. K., & Hagiwara, M.
Affiliations
Policy Analysis (United States) (US)
Venue
CNS Drugs
Published
2011-01
Volume
25
Issue
1
Pages
53-66
ISSN
1172-7047 (ISSN-L)
OpenAlex
W66124219
Cited by
28
References
20
Citations by year
2025: 1 · 2024: 5 · 2023: 2 · 2022: 2 · 2021: 3 · 2020: 2 · 2018: 1 · 2017: 3 · 2016: 2 · 2014: 1 · 2013: 5 · 2012: 1
FWCI
1.74
Type
journal article
Language
en
Open access
closed
Locations
  • CNS Drugs (publishedVersion)
  • PubMed (publishedVersion)
Funders
School of Medicine, Duke University
Topics
  • Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Healthcare Policy and Management
Keywords
Parkinson's disease, medication adherence, levodopa/carbidopa/entacapone, entacapone, carbidopa, levodopa, health care utilization, health care costs, hospitalization, proportion of days covered
MeSH terms
Antiparkinson Agents, Carbidopa, Catechols, Delivery of Health Care, Humans, Levodopa, Nitriles, Parkinson Disease, Patient Compliance, Retrospective Studies, Cohort Studies, Health Care Costs

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Association between Adherence to Levodopa/Carbidopa/Entacapone Therapy and Healthcare Utilization and Costs among Patients with Parkinsonʼs Disease: A Retrospective Claims-Based Analysis. https://app.cochat.ai/papers/10.2165/11538970-000000000-00000
The paper
Delea, T. E., Thomas, S. K., & Hagiwara, M. (2011). The Association between Adherence to Levodopa/Carbidopa/Entacapone Therapy and Healthcare Utilization and Costs among Patients with Parkinsonʼs Disease: A Retrospective Claims-Based Analysis. CNS Drugs. https://doi.org/10.2165/11538970-000000000-00000

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.